E

EG

EG

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
EG Live QuoteReal-time
$421.96
+$27.18(+6.88%)1M
Day Range$414.60 – $422.30
Open$417.81
Previous Close$420.04
Volume377.3K
Key Financials & Valuation
Fundamental balance sheet & market metrics
FINANCIAL SERVICES
Market Cap$15.63B
P/E Ratio (TTM)8.9
Forward P/E6.8
EPS (TTM)$47.59
Price to Book1.1
Dividend Yield1.90%
Beta (Volatility)0.23
IndustryINSURANCE - REINSURANCE
52-Week RangeCurrent: $421.96 (89%)
Low: $299.43High: $437.76
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$437.94+192.0% upside

Insider Buys

0

$0

Insider Sales

2

$3.10M

Total Volume

$3.10M

2 transactions

Net Activity

$3.10M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Galtney William F Jr

Dir

0 buys2 sells

$3.10M total

Trading History
EG insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 10, 2026

1 weeks ago

Galtney William F Jr

Dir

Director
Sell2.5K$414.29$1.04M

Nov 6, 2026

2 weeks ago

Galtney William F Jr

Dir

Director
Sell5.0K$412.41$2.06M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
EG Buy Conviction0%
Industry Rank#231 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

EG has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. EG ranks #231 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for EG

Over the last 90 days, corporate insiders at EG (EG) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 2 were sales. The total volume of insider trading reached $3.10M.

The net insider activity for EG shows a net selling bias of $3.10M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Galtney William F Jr (Dir), who traded 5.0K shares valued at $2.06M on Nov 6, 2026.

Live Market News & Developments
Aggregated real-time headlines for EG (EG)
6 updates

EG Stock Near 52-Week High: A Signal for Investors to Hold Tight?

Yahoo Finance2d ago

Everest Group (EG) Stock Forecast and Price Target 2026 $EG

MarketBeat3d ago

Everest Group (NYSE:EG) - Stock Analysis

Simply Wall St3d ago

Why Everest Group (NYSE:EG) Stock Rose 1.3% on the S&P 500 to a 52-Week High: Investors Bid Up the Reinsurer in a Defensive Rotation

kalkine.com3d ago

EG Shareholder Alert: Everest Group, Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

PR Newswire20h ago

Everest Group, Ltd. (EG) Latest Stock News & Headlines - Yahoo Finance

Yahoo! Finance Canada2d ago

Related News & Analyst Reports

Read original insights and educational research covering EG and the Unknown sector.

August 5, 2026

The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings

An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.

Read Analysis
August 3, 2026

The Lockup Expiration Wave: Venture Capital Post-IPO Exit Strategies

A data-driven analysis of how venture capital firms and pre-IPO insiders manage lockup expirations, detailing block trade execution, distribution methods, and stock price impact.

Read Analysis
August 3, 2026

Lock-up Expiration Frontrunning: How Venture Funds Manage Large Block Trades

When lock-up periods expire, venture funds use block trades, 10b-18 programs, and coordinated secondary offerings to exit large positions. This report reveals the strategies that minimize price impact, and how retail investors can track them.

Read Analysis
May 4, 2026

The Y Combinator Spinoff Trade: Spotting Alpha in Post-Demo Day IPOs

Y Combinator alumni companies show distinctive insider liquidity patterns after IPO. This report maps Form 4 activity at YC-backed public companies to identify when founder and early-investor selling subsides and conviction buying begins.

Read Analysis
March 26, 2026

Legal vs. Illegal Insider Trading: Setting the Record Straight

The line between legal and illegal insider trading is narrower than most investors realize. This explainer covers the material non-public information standard, the Misappropriation Theory, and how regulators reconstruct trading chronologies.

Read Analysis
February 26, 2026

The Role of Insider Trading in M&A: Deciphering the Pre-Merger Signals

M&A deals are the most fertile ground for illegal insider trading, and for legal cluster buys that signal a company is strategically attractive. This guide separates the legal signal from the illegal noise in M&A-adjacent Form 4 activity.

Read Analysis

FAQs About EG Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for EG.

Based on SEC Form 4 disclosures, the Insider Confidence Score for EG is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for EG is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.